Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
Abbott USD 8.45B 21M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Avrobio USD 22.93M 90.94M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Enanta Pharmaceuticals USD 49.96M 5.64M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Incyte USD 826.07M 121.75M 2023-12
J&J USD 16.57B 435M 2023-12
Merck USD 16.56B 6.35B 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Takeda JPY 1.09T 202.38B 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Xencor USD 79.7M 2.27M 2023-12



Karyopharm Therapeutics Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.